Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Average EV/EBIT Ratio

EV/EBIT Ratio

The today ev/ebit ratio is 18.39x as of Friday, June 26, 2026, shown against its trailing averages.

DGX EV/EBIT Ratio

DGX Average EV/EBIT Ratio

DGX EV/EBIT Ratio Averages

EV/EBIT RATIO TODAY

18.39x

EV/EBIT RATIO TTM

17.88x

EV/EBIT RATIO 3Y

17.63x

EV/EBIT RATIO 5Y

14.72x

EV/EBIT RATIO 10Y

14.60x

EV/EBIT RATIO 15Y

13.28x

EV/EBIT RATIO 20Y

12.64x

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis